A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

The Bronchodilator Drugs market in Central America is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$46.90m by 2024. Moreover ...

Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA) related rulings from around ...

CNS stimulants are a type of medication that can help with low energy and concentration caused by sleep disruptions from sleep apnea. Methylxanthine bronchodilators are muscle relaxers that make ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

The drug was administered twice-daily using a ... phosphodiesterase 3 and 4 (PDE3 and PDE4), and is thought to combine bronchodilator and anti-inflammatory properties in one compound.

Asthma treatment costs the NHS millions each year, with inhalers being a significant part of this expenditure. Dr. Potter highlighted the wide range of inhalers available, from basic bronchodilators ...

Childhood asthma leads to over 10 million missed school days annually in the U.S., making it a significant contributor to chronic illness-related school absenteeism. In the U.S., nearly 25 million ...